abstract |
The invention relates to a compound of formula (I) as detailed in the description, one of its pharmaceutically acceptable salts, or a composition comprising the same, for use in the prevention or treatment of related conditions. glucose intolerance, pathological conditions related to insulin deficiency, non-alcoholic fatty liver disease and / or obesity. 5 |